Biography and Research Information
OverviewAI-generated summary
Ples Spradley's research focuses on the clinical application of biomarkers in cancer treatment. In a 2021 publication, Spradley investigated the role of C-reactive protein monitoring in the early discontinuation of immune oncology therapy for stage IV non-small cell lung cancer. This study aimed to assess whether such monitoring could be done without negatively impacting patient outcomes. Spradley has one publication in total and collaborates with Ahmad Mazen Safar at the University of Arkansas for Medical Sciences, with whom they share one publication.
Metrics
- Publications: 1
Selected Publications
-
Monitoring C-reactive protein facilitates early discontinuation of immune oncology without compromising outcomes in stage IV non-small cell lung cancer. (2021)
Collaboration Network
Top Collaborators
- Monitoring C-reactive protein facilitates early discontinuation of immune oncology without compromising outcomes in stage IV non-small cell lung cancer.
- Monitoring C-reactive protein facilitates early discontinuation of immune oncology without compromising outcomes in stage IV non-small cell lung cancer.
Similar Researchers
Based on overlapping research topics